Financhill
Back

Capricor Therapeutics Quote, Financials, Valuation and Earnings

Buy
73

CAPR
Capricor Therapeutics

Last Price:
6.22
Seasonality Move:
8.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Capricor Therapeutics Price Quote

$6.22
+0.02 (+10.28%)
(Updated: May 18, 2024 at 5:39 AM ET)

Capricor Therapeutics Key Stats

Buy
73
Capricor Therapeutics (CAPR) is a Buy

Day range:
$5.79 - $6.53
52-week range:
$2.68 - $8.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.48
P/B ratio:
10.7%

Volume:
755.1K
Avg. volume:
371.9K
1-year change:
42.69%
Market cap:
$197.2M
Revenue:
$25.2M
EPS:
$-0.83

How Much Does Capricor Therapeutics Make?

Is Capricor Therapeutics Growing As A Company?

  • What Is Capricor Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.64%
  • What Is Capricor Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Capricor Therapeutics Stock Price Performance

What Is Capricor Therapeutics 52-Week High & Low?

Capricor Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Capricor Therapeutics?

Is Capricor Therapeutics Cash Flow Positive?

  • What Is CAPR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.1M
  • What Is Capricor Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $27.9M
  • What Is Capricor Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.2M

Capricor Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CAPR return on invested capital is -252.29%
  • What Is Capricor Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -49.58%
  • What Is CAPR Return On Equity?
    ROE is a measure of profitability and is -252.29%

Capricor Therapeutics Earnings Date & Stock Price

Capricor Therapeutics Competitors

Capricor Therapeutics Dividend Yield

Data Unavailable

Capricor Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -173.54%
Revenue: 64.29% -49.41%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.80
Upside from Last Price: 219.35%

Major Shareholders

  • How many CAPR shares are owned by institutional investors?
    8M CAPR shares are owned by institutional investors
  • How many CAPR shares are owned by insiders?
    3.8M CAPR shares are owned by insiders